BeOne Medicines (ONC) Return on Capital Employed (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 310.00 |
| Dec 31, 2025 | 338.00 |
| Sep 30, 2025 | 658.00 |
| Jun 30, 2025 | 498.00 |
| Mar 31, 2025 | 793.00 |
| Dec 31, 2024 | 777.00 |
| Sep 30, 2024 | 33.00 |
| Jun 30, 2024 | 485.00 |
| Mar 31, 2024 | 285.00 |
| Dec 31, 2023 | -157.00 |
| Sep 30, 2023 | 623.00 |
| Jun 30, 2023 | 249.00 |
| Mar 31, 2023 | -397.00 |
| Dec 31, 2022 | -1,447.00 |
| Sep 30, 2022 | -172.00 |
| Jun 30, 2022 | -108.00 |
| Mar 31, 2022 | -450.00 |
| Dec 31, 2021 | 2,023.00 |
| Sep 30, 2021 | -295.00 |
| Jun 30, 2021 | -362.00 |
| Mar 31, 2021 | 1,037.00 |
| Dec 31, 2020 | 140.00 |
| Sep 30, 2020 | 356.00 |
| Jun 30, 2020 | 685.00 |
| Mar 31, 2020 | 1,826.00 |
| Dec 31, 2019 | -1,810.00 |
| Sep 30, 2019 | -1,213.00 |
| Jun 30, 2019 | 238.00 |
| Mar 31, 2019 | -509.00 |
| Dec 31, 2018 | -519.00 |
| Sep 30, 2018 | -1,112.00 |
| Jun 30, 2018 | -481.00 |
| Mar 31, 2018 | -180.00 |
| Dec 31, 2017 | -612.00 |
| Sep 30, 2017 | 4,354.00 |
| Jun 30, 2017 | -495.00 |
| Mar 31, 2017 | -245.00 |
| Dec 31, 2016 | 861.00 |
| Sep 30, 2016 | -1,372.00 |
| Jun 30, 2016 | 251.00 |